Berry Components and Blood Sugar & Fat Metabolism

May 2, 2019 updated by: Janet Novotny, USDA Beltsville Human Nutrition Research Center
The primary objective of this study is to determine which components of berries improve glucose metabolism and increase fat oxidation in humans.

Study Overview

Detailed Description

The aim of this study is to improve understanding of how diet can regulate glucose metabolism and fuel use. Previous human and animal studies have demonstrated that berries can improve gluco-regulation and increase fat oxidation. The aim of this study is to determine which component of berries is conveying this health benefit.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Beltsville, Maryland, United States, 20705
        • USDA-ARS Beltsville Human Nutrition Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy non-smoker
  • able to understand consent

Exclusion Criteria:

  • Body Mass Index less than 25 kg/m2
  • pregnant, lactating, having given birth in the past year
  • allergy to berries
  • blood glucose greater than 125 mg/dL
  • history of bariatric surgery or nutrient malabsorption disease
  • diagnosis or treatment of cancer in past three years
  • type 2 diabetes requiring the use of diabetes pills, insulin, or non-insulin shots

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Mixed Berry Diet
Participants will receive between 400 to 800 grams of mixed berries daily, as a proportion of their daily caloric intake added to their base diet. The base diet will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet.
Mixed Berry Treatment
Other: Carbohydrate Control Jello
Participants will receive between 400 to 800 grams of strawberry jello daily, as a proportion of their daily caloric intake added to their base diet. The jello will be matched to the mixed berries in both total carbohydrate level and gram quantity. The base diet will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet.
Carbohydrate Control
Other: Fiber Enriched Jello
Participants will receive between 400 to 800 grams of fiber enriched strawberry jello daily, as a proportion of their daily caloric intake added to their base diet. The jello will be matched to the mixed berries in both total carbohydrate level and fiber content, and in the same gram quantity. The base diet will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet.
Fiber Control
Other: Low Fiber Mixed Berry Juice
Participants will receive 1 liter per day of low fiber mixed berry juice added to their base diet. The juice will be squeezed from the mixed berries, then filtered. The sugar level of the juice will match that of the mixed berries. The base diet will be prepared using traditional American foods with a macronutrient composition representative of a typical American diet.
Anthocyanin Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glucose Metabolism Phase 1
Time Frame: Day 8
Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for glucose in mmol/L.
Day 8
Glucose Metabolism Phase 2
Time Frame: Day 29
Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for glucose in mmol/L.
Day 29
Glucose Metabolism Phase 3
Time Frame: Day 50
Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for glucose in mmol/L.
Day 50
Glucose Metabolism Phase 4
Time Frame: Day 71
Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for glucose in mmol/L.
Day 71

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insulin sensitivity
Time Frame: Day 8, 29, 50, 71
Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for insulin in units of microIU/mL.
Day 8, 29, 50, 71
Fat trafficking
Time Frame: Day 8, 29, 50, 71
Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for non-esterified fatty acids in mmol/L.
Day 8, 29, 50, 71
Peripheral mononuclear blood cells energetics
Time Frame: Day 8, 29, 50, 71
Blood cells called peripheral mononuclear blood cells will be isolated and analyzed for mitochondrial function/oxygen consumption in nmol/ml.
Day 8, 29, 50, 71
Metabolic Fuel Use
Time Frame: Day 7-8, 28-29, 49-50, 70-71
Subjects will spend the night in an indirect calorimeter to measure their oxygen consumption and carbon dioxide evolution which will be used to calculate the dietary energy source being oxidized, expressed as respiratory quotient which is a unitless ratio of liters of O2 inhaled to liters of CO2 exhaled.
Day 7-8, 28-29, 49-50, 70-71

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolomics in blood
Time Frame: Day 8, 29, 50, 71
Blood metabolomics profiling will be conducted by gas chromatography and liquid chromatography / time-of-flight mass spectrometry. Selected intensity of biochemicals in blood with mass ranging from 50 to 800 molecular weight will be assessed.
Day 8, 29, 50, 71

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2018

Primary Completion (Actual)

June 28, 2018

Study Completion (Actual)

June 28, 2018

Study Registration Dates

First Submitted

January 3, 2018

First Submitted That Met QC Criteria

March 7, 2018

First Posted (Actual)

March 8, 2018

Study Record Updates

Last Update Posted (Actual)

May 7, 2019

Last Update Submitted That Met QC Criteria

May 2, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • HS59

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Mixed Berry Diet

3
Subscribe